References:
1. Shim A, Song J-H, Kwon B-E, Lee J-J, Ahn J-H, Kim Y-J, et al. Therapeutic and prophylactic activity of itraconazole against human rhinovirus infection in a murine model. Scientific reports. 2016;6:23110. doi:10.1038/srep23110
2. Steel HC, Tintinger GR, Theron AJ, Anderson R. Itraconazole‐mediated inhibition of calcium entry into platelet‐activating factor‐stimulated human neutrophils is due to interference with production of leukotriene B4. Clinical & Experimental Immunology. 2007;150(1):144-50. doi:10.1111/j.1365-2249.2007.03470.x
3. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet. 2020;395(10223):497-506. doi:10.1016/S0140-6736(20)30183-5
4. Schloer S, Goretzko J, Kühnl A, Brunotte L, Ludwig S, Rescher U. The clinically licensed antifungal drug itraconazole inhibits influenza virus in vitro and in vivo. Emerging microbes & infections. 2019;8(1):80-93. doi:10.1080/22221751.2018.1559709
5. Trznadel-Grodzka E, Błaszkowski M, Rotsztejn H. Investigations of seborrheic dermatitis. Part II. Influence of itraconazole on the clinical condition and the level of selected cytokines in seborrheic dermatitis. Advances in Hygiene & Experimental Medicine/Postepy Higieny i Medycyny Doswiadczalnej. 2012;66. doi:10.5604/17322693.1019648
6. Wu C, Liu Y, Yang Y, Zhang P, Zhong W, Wang Y, et al. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharmaceutica Sinica B. 2020. doi:10.1016/j.apsb.2020.02.008
7. Liu W, Morse JS, Lalonde T, Xu S. Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019‐nCoV. Chembiochem. 2020. doi:10.1002/cbic.202000047
8. Chu CK, Gadthula S, Chen X, Choo H, Olgen S, Barnard DL, et al. Antiviral activity of nucleoside analogues against SARS-coronavirus (SARS-CoV). Antiviral Chemistry and Chemotherapy. 2006;17(5):285-9. doi:10.1177/095632020601700506
9. Puerta-Arias JD, Pino-Tamayo PA, Arango JC, Salazar-Peláez LM, González A. Itraconazole in combination with neutrophil depletion reduces the expression of genes related to pulmonary fibrosis in an experimental model of paracoccidioidomycosis. Medical mycology. 2018;56(5):579-90. doi:10.1093/mmy/myx087
10. Jesus FP, Ferreiro L, Loreto ÉS, Pilotto MB, Ludwig A, Bizzi K, et al. In vitro synergism observed with azithromycin, clarithromycin, minocycline, or tigecycline in association with antifungal agents against Pythium insidiosum. Antimicrobial agents and chemotherapy. 2014;58(9):5621-5.doi:10.1128/AAC.02349-14